InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by 권영이, Chairman & CEO. Director active across 2 companies, notably 삼익제약. Cumulatively, 6 disclosures have been logged. Activity tracked since 26 March 2026. The latest transaction was disclosed on 27 May 2026 (Sale). Regulator: DART (FSS). The full history is free.
6 of 6 declarations
Kwon Young-hee is the chairman and CEO of Samik Pharmaceutical. In this role, he is responsible for the strategic and operational direction of the company. Samik Pharmaceutical specializes in the pharmaceutical sector. Kwon Young-hee plays a crucial role in guiding and growing the company.